Acute renal disease in patients with ovarian peritoneal carcinomatosis treated with cytoreduction and HIPEC: the influence of surgery and the cytostatic agent used.
Álvaro Jesús Gómez-RuizAlida González-GilJosé GilFelipe Alconchel-GagoÁlvaro Navarro-BarriosElena Gil-GómezJerónimo MartínezAníbal NietoCarlos García-PalencianoPedro Antonio Cascales-CamposPublished in: Langenbeck's archives of surgery (2021)
ARD has a multifactorial origin. Cisplatin was associated with the development of a higher rate of ARD than paclitaxel. Diagnosis of ARD did not correlate with worse survival figures.